-
J Diabetes Investig · May 2020
Letter Case ReportsNivolumab-induced fulminant type 1 diabetes with precipitous fall in C-peptide level.
- Masaaki Miyauchi, Masao Toyoda, Jie Zhang, Naoko Hamada, Takashi Yamawaki, Jun Tanaka, Kazuki Harada, Fumihiro Kashizaki, and Masafumi Fukagawa.
- Miyauchi Diabetes Clinic, Hadano, Japan.
- J Diabetes Investig. 2020 May 1; 11 (3): 748-749.
AbstractWe describe here a case of nivolumab-induced type 1 diabetes, which developed within 9 days of treatment. The case highlights the importance of frequent monitoring of glucose after initiation of nivolumab treatment.© 2019 The Authors. Journal of Diabetes Investigation published by Asian Association for the Study of Diabetes (AASD) and John Wiley & Sons Australia, Ltd.
Notes
Knowledge, pearl, summary or comment to share?You can also include formatting, links, images and footnotes in your notes
- Simple formatting can be added to notes, such as
*italics*,_underline_or**bold**. - Superscript can be denoted by
<sup>text</sup>and subscript<sub>text</sub>. - Numbered or bulleted lists can be created using either numbered lines
1. 2. 3., hyphens-or asterisks*. - Links can be included with:
[my link to pubmed](http://pubmed.com) - Images can be included with:
 - For footnotes use
[^1](This is a footnote.)inline. - Or use an inline reference
[^1]to refer to a longer footnote elseweher in the document[^1]: This is a long footnote..